Mitochondria-Targeted Drug Development Summit

Abliva kommer att delta och presentera vid konferensen Mitochondria-Targeted Drug Development Summit i Boston, MA, USA. Eventet hålls den 22 – 24 februari 2022.

VD Ellen Donnelly kommer att presentera under sessionen Patient-Focused Drug Development for Mitochondrial Disease.

Synopsis:

• Highlighting the impact of patient input on research and development at Abliva
• Providing an overview of the multiple therapeutic options for mitochondrial disease being pursued at Abliva
• Presenting placebo controlled PMD patient data from our lead asset, KL1333